Abstract
Genetic susceptibility to colorectal cancer is caused by rare pathogenic mutations and common genetic variants that contribute to familial risk. Here we report the results of a two-stage association study with 18,299 cases of colorectal cancer and 19,656 controls, with follow-up of the most statistically significant genetic loci in 4,725 cases and 9,969 controls from two Asian consortia. We describe six new susceptibility loci reaching a genome-wide threshold of P<5.0E-08. These findings provide additional insight into the underlying biological mechanisms of colorectal cancer and demonstrate the scientific value of large consortia-based genetic epidemiology studies.
Original language | English (US) |
---|---|
Article number | 7138 |
Journal | Nature communications |
Volume | 6 |
DOIs | |
State | Published - Jul 7 2015 |
Externally published | Yes |
ASJC Scopus subject areas
- Chemistry(all)
- Biochemistry, Genetics and Molecular Biology(all)
- General
- Physics and Astronomy(all)
Access to Document
Other files and links
Fingerprint
Dive into the research topics of 'Genome-wide association study of colorectal cancer identifies six new susceptibility loci'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
Genome-wide association study of colorectal cancer identifies six new susceptibility loci. / Schumacher, Fredrick R.; Schmit, Stephanie L.; Jiao, Shuo et al.
In: Nature communications, Vol. 6, 7138, 07.07.2015.Research output: Contribution to journal › Article › peer-review
}
TY - JOUR
T1 - Genome-wide association study of colorectal cancer identifies six new susceptibility loci
AU - Schumacher, Fredrick R.
AU - Schmit, Stephanie L.
AU - Jiao, Shuo
AU - Edlund, Christopher K.
AU - Wang, Hansong
AU - Zhang, Ben
AU - Hsu, Li
AU - Huang, Shu Chen
AU - Fischer, Christopher P.
AU - Harju, John F.
AU - Idos, Gregory E.
AU - Lejbkowicz, Flavio
AU - Manion, Frank J.
AU - McDonnell, Kevin
AU - McNeil, Caroline E.
AU - Melas, Marilena
AU - Rennert, Hedy S.
AU - Shi, Wei
AU - Thomas, Duncan C.
AU - Van Den Berg, David J.
AU - Hutter, Carolyn M.
AU - Aragaki, Aaron K.
AU - Butterbach, Katja
AU - Caan, Bette J.
AU - Carlson, Christopher S.
AU - Chanock, Stephen J.
AU - Curtis, Keith R.
AU - Fuchs, Charles S.
AU - Gala, Manish
AU - Giocannucci, Edward L.
AU - Gogarten, Stephanie M.
AU - Hayes, Richard B.
AU - Henderson, Brian
AU - Hunter, David J.
AU - Jackson, Rebecca D.
AU - Kolonel, Laurence N.
AU - Kooperberg, Charles
AU - Kury, Sebastian
AU - Lacroix, Andrea
AU - Laurie, Cathy C.
AU - Laurie, Cecelia A.
AU - Lemire, Mathiew
AU - Levine, David
AU - Ma, Jing
AU - Makar, Karen W.
AU - Qu, Conghui
AU - Taverna, Darin
AU - Ulrich, Cornelia M.
AU - Wu, Kana
AU - Kono, Suminori
AU - West, Dee W.
AU - Berndt, Sonja I.
AU - Bezieau, Stephane
AU - Brenner, Hermann
AU - Campbell, Peter T.
AU - Chan, Andrew T.
AU - Chang-Claude, Jenny
AU - Coetzee, Gerhard A.
AU - Conti, David V.
AU - Duggan, David
AU - Figueiredo, Jane C.
AU - Fortini, Barbara K.
AU - Gallinger, Steven J.
AU - Gauderman, W. James
AU - Giles, Graham
AU - Green, Roger
AU - Haile, Robert
AU - Harrison, Tabitha A.
AU - Hoffmeister, Michael
AU - Hopper, John L.
AU - Hudson, Thomas J.
AU - Jacobs, Eric
AU - Iwasaki, Motoki
AU - Jee, Sun Ha
AU - Jenkins, Mark
AU - Jia, Wei Hua
AU - Joshi, Amit
AU - Li, Li
AU - Lindor, Noralene M.
AU - Matsuo, Keitaro
AU - Moreno, Victor
AU - Mukherjee, Bhramar
AU - Newcomb, Polly A.
AU - Potter, John D.
AU - Raskin, Leon
AU - Rennert, Gad
AU - Rosse, Stephanie
AU - Severi, Gianluca
AU - Schoen, Robert E.
AU - Seminara, Daniela
AU - Shu, Xiao Ou
AU - Slattery, Martha L.
AU - Tsugane, Shoichiro
AU - White, Emily
AU - Xiang, Yong Bing
AU - Zanke, Brent W.
AU - Zheng, Wei
AU - Le Marchand, Loic
AU - Casey, Graham
AU - Gruber, Stephen B.
AU - Peters, Ulrike
N1 - Funding Information: CORECT: this work was supported by the National Cancer Institute, National Institutes of Health under RFA # CA-09-002, NIH/NCI U19 CA148107. The content of this manuscript does not necessarily reflect the views or policies of the National Cancer Institute or any of the collaborating centres in the CORECT consortium, nor does mention of trade names, commercial products or organizations imply endorsement by the US Government or the CORECT Consortium. ASTERISK: we are very grateful to Dr Bruno Buecher without whom this project would not have existed. We also thank all those who agreed to participate in this study, including the patients and the healthy control persons, as well as all the physicians, technicians and students. DACHS: we thank all participants and cooperating clinicians, and Ute Handte-Daub, Renate Hettler-Jensen, Utz Benscheid, Muhabbet Celik and Ursula Eilber for excellent technical assistance. GECCO: we thank all those at the GECCO Coordinating Center for helping bring together the data and people that made this project possible. HPFS, NHS and PHS: we acknowledge Patrice Soule and Hardeep Ranu of the Dana-Farber Harvard Cancer Center High-Throughput Polymorphism Core who assisted in the genotyping for NHS, HPFS and PHS under the supervision of Dr Immaculata Devivo and Dr David Hunter, Qin (Carolyn) Guo and Lixue Zhu who assisted in programming for NHS and HPFS and Haiyan Zhang who assisted in programming for the PHS. We thank the participants and staff of the Nurses’ Health Study and the Health Professionals Follow-Up Study, for their valuable contributions as well as the following state cancer registries for their help: AL, AZ, AR, CA, CO, CT, DE, FL, GA, ID, IL, IN, IA, KY, LA, ME, MD, MA, MI, NE, NH, NJ, NY, NC, ND, OH, OK, OR, PA, RI, SC, TN, TX, VA, WA, WY. In addition, this study was approved by the Connecticut Department of Public Health (DPH) Human Investigations Committee. Certain data used in this publication were obtained from the DPH. We assume full responsibility for analyses and interpretation of these data. PLCO: we thank Drs Christine Berg and Philip Prorok, Division of Cancer Prevention, National Cancer Institute, the Screening Center investigators and staff or the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial, Mr. Tom Riley and staff, Information Management Services Inc., Ms Barbara O’Brien and staff, Westat Inc. and Drs Bill Kopp, Wen Shao and staff, SAIC-Frederick. Most importantly, we acknowledge the study participants for their contributions for making this study possible. The statements contained herein are solely those of the authors and do not represent or imply concurrence or endorsement by NCI. PMH: we thank the study participants and staff of the Hormones and Colon Cancer study. WHI: we thank the WHI investigators and staff for their dedication, and the study participants for making the program possible. A full listing of WHI investigators can be found at https://cleo.whi.org/researchers/ Documents%20%20Write%20a%20Paper/WHI%20Investigator%20Short%20List.pdf. ACC: we thank all study participants and research staff of all studies for their contributions and commitment to this project, Regina Courtney for DNA preparation and Jing He for data processing. Publisher Copyright: © 2015 Macmillan Publishers Limited.
PY - 2015/7/7
Y1 - 2015/7/7
N2 - Genetic susceptibility to colorectal cancer is caused by rare pathogenic mutations and common genetic variants that contribute to familial risk. Here we report the results of a two-stage association study with 18,299 cases of colorectal cancer and 19,656 controls, with follow-up of the most statistically significant genetic loci in 4,725 cases and 9,969 controls from two Asian consortia. We describe six new susceptibility loci reaching a genome-wide threshold of P<5.0E-08. These findings provide additional insight into the underlying biological mechanisms of colorectal cancer and demonstrate the scientific value of large consortia-based genetic epidemiology studies.
AB - Genetic susceptibility to colorectal cancer is caused by rare pathogenic mutations and common genetic variants that contribute to familial risk. Here we report the results of a two-stage association study with 18,299 cases of colorectal cancer and 19,656 controls, with follow-up of the most statistically significant genetic loci in 4,725 cases and 9,969 controls from two Asian consortia. We describe six new susceptibility loci reaching a genome-wide threshold of P<5.0E-08. These findings provide additional insight into the underlying biological mechanisms of colorectal cancer and demonstrate the scientific value of large consortia-based genetic epidemiology studies.
UR - http://www.scopus.com/inward/record.url?scp=84936745391&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84936745391&partnerID=8YFLogxK
U2 - 10.1038/ncomms8138
DO - 10.1038/ncomms8138
M3 - Article
C2 - 26151821
AN - SCOPUS:84936745391
VL - 6
JO - Nature Communications
JF - Nature Communications
SN - 2041-1723
M1 - 7138
ER -